Lucas de Vries Defends His PHD Combining Physics, Deep Learning and Medical Imaging
Lucas de Vries, PhD Candidate Deep Learning for Neuroradiology at Amsterdam UMC, shared on LinkedIn:
”On October 1st, I defended my PhD thesis, ‘Revisiting CT perfusion for acute ischemic stroke with deep learning’.
Iām happy to share that I have now officially obtained my PhD.
In my thesis, I explored how we can combine physics, deep learning, and medical imaging.
Specifically, I investigated how physics-informed deep learning can improve the analysis of dynamic CT perfusion imaging for acute ischemic stroke.
The full thesis is available online (see the comments below) and is based on the following five publications:
– PerfU-Net: Baseline infarct estimation from CT perfusion source data for acute ischemic stroke (Medical Image Analysis)
– Spatio-temporal physics-informed learning: A novel approach to CT perfusion analysis in acute ischemic stroke (Medical Image Analysis)
– Accelerating physics-informed neural fields for fast CT perfusion analysis in acute ischemic stroke (MIDL)
– Neural fields for tissue attenuation curve reconstruction in sparsely sampled time-resolved CT (MIDL)
– Automated collateral assessment restricted to the hypoperfused area for distal vessel occlusions in ischemic stroke (European Radiology)
A big thanks to my team, Efstratios Gavves, Henk Marquering, Charles Majoie, and Bart Emmer, for their guidance over the past few years, to all my co-authors, and to my paranimfs Julius de Vries and Roel van Herten for their endless support.
With this chapter coming to an end, I will soon be moving to Paris to start a new adventure.
If you are based in Paris or have connections there, I would appreciate any recommendations or introductions, whether related to housing, research, machine learning, or just meeting new people.
Always happy to grab a coffee and connect!”
Read the full article here.
Article: Revisiting CT perfusion for acute ischemic stroke with deep learning
Authors: Lucas de Vries

Stay updated with Hemostasis Today.
-
Mar 15, 2026, 15:55Rare Diseases, Plasma-Derived Medicines and the Elephant in the Room ā Part 2
-
Mar 15, 2026, 14:09Abdul Mannan: A Red Eye, a Blood Clot, and Ibrutinib – The Clinical Tightrope
-
Mar 15, 2026, 14:02Denise M: Precision Hemostasis in Patient Blood Management
-
Mar 15, 2026, 13:57Abdulrahman Nasiri: D14 Bone Marrow Biopsy in AML Induction in the Era of Targeted Therapies
-
Mar 15, 2026, 13:52Valentin Ortiz-Maldonado: High-Impact Innovation in CAR-T Therapy Can Emerge From Academic Programmes
-
Mar 15, 2026, 13:45Tareq Abadl: Has Anyone Here Ever Taken an ALP Test Before?
-
Mar 14, 2026, 21:30Ayman Elbadawi: Why Does Stent Thrombosis Still Occur? Insights from the NCDR Data
-
Mar 14, 2026, 20:03Edward Adomako: Recognizing Thrombotic Thrombocytopenic Purpura as A Life-Threatening Emergency
-
Mar 14, 2026, 19:28Vishnu Priya Pulipati: Statins Beyond Cholesterol for Plaque Biology and Cardiovascular Risk Reduction